Advances in clinical laboratory techniques and molecular analysis are reshaping our approach to therapy and diagnosis. Explore emerging diagnostic technology and the latest insights in the microbial community in these webinars.
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a novel virus that causes COVID-19 and has considerable variability in clinical outcomes among infected patients. The GENCOV stu...
In genomics, as in life, you need to be in the right place at the right time, and you need integrity, to be credible. Since the availability of the human genome sequence, there's been an...
Traumatic brain injury (TBI) is a widespread global health concern, impacting approximately 10 million individuals annually. Beyond the initial acute phase, TBI often results in enduring neu...
Immunoassays and mass spectrometric assays are the two major methodologies in contemporary clinical chemistry laboratories. While immunoassays are highly automated and offer a faster turnaro...
The next-generation sequencing (NGS) technologies have led to shifting paradigms for hereditary cancers genetic testing. With the increasing sensitivity of new technologies and the reduction...
When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along wit...
In the next five years, the majority of clinical diagnostic labs competing to offer NGS oncology testing will be performing comprehensive genomic profiling (CGP). Yet scaling to CGP introduc...
Acute cough is one of the most common reasons for consulting in primary care thus driving considerable antibiotic use and health-care costs. Currently, identification of microbial etiology i...
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
Lateral flow assays (LFA) are simple diagnostic tools that can be used to detect a variety of biomolecules that include biomarkers, pathogens, and environmental contaminants. Many industries...
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
Despite an overall good performance on all laboratory procedures used to detect monoclonal (M) proteins or paraproteins, mis- or false-diagnoses have been seen using electrophoresis methods,...
We will discuss the Digital LightCycler System, a digital PCR (dPCR) system for DNA and RNA with 6-color capability for flexible, multiplexed biomarker detection. With advances in sensitivit...
Molecular diagnostic assay development and design is no simple task, and several factors affect the performance and usability of a test. Diagnostic companies can enhance assay stability and...
Quantitative genetic analysis plays a critical role in the research and development of novel biotherapeutics. As a sensitive and precise method for quantitating specific nucleic acid targets...
Early detection is critical in combating invasive fungal and mold infections, where every moment counts. Traditional culture-based methods often fall short, with lengthy turnaround times and...